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Abstract
Background: Patient Safety Indicators (PSI) are being modestly used in Spain, somewhat due to concerns on their
empirical properties. This paper provides evidence by answering three questions: a) Are PSI differences across
hospitals systematic -rather than random?; b) Do PSI measure differences among hospital-providers -as opposed to
differences among patients?; and, c) Are measurements able to detect hospitals with a higher than “expected”
number of cases?
Methods: An empirical validation study on administrative data was carried out. All 2005 and 2006 publicly-funded
hospital discharges were used to retrieve eligible cases of five PSI: Death in low-mortality DRGs (MLM); decubitus
ulcer (DU); postoperative pulmonary embolism or deep-vein thrombosis (PE-DVT); catheter-related infections (CRI),
and postoperative sepsis (PS). Empirical Bayes statistic (EB) was used to estimate whether the variation was
systematic; logistic-multilevel modelling determined what proportion of the variation was explained by the
hospital; and, shrunken residuals, as provided by multilevel modelling, were plotted to flag hospitals performing
worse than expected.
Results: Variation across hospitals was observed to be systematic in all indicators, with EB values ranging from 0.19
(CI95%:0.12 to 0.28) in PE-DVT to 0.34 (CI95%:0.25 to 0.45) in DU. A significant proportion of the variance was
explained by the hospital, once patient case-mix was adjusted: from a 6% in MLM (CI95%:3% to 11%) to a 24%
(CI95%:20% to 30%) in CRI. All PSI were able to flag hospitals with rates over the expected, although this capacity
decreased when the largest hospitals were analysed.
Conclusion: Five PSI showed reasonable empirical properties to screen healthcare performance in Spanish
hospitals, particularly in the largest ones.
Background
The Spanish National Health Service, like others, has
become influenced by the Patient Safety movement. Evi-
dence from two reports on Spanish hospitals, following
other international works on adverse events [1-7],
inspired the debate. The first one, showed an in-patient
incidence of adverse events ranging from 5.6% to 16.1%,
being avoidable between 17% and 41% of them [8]. The
second one, found an incidence of adverse events
amenable to health care up to 10.1% [9]. As a matter of
fact, these findings contributed to steer the inclusion of
Patient Safety Indicators (PSI) within the sets of
National and Regional Quality Indicators, being mod-
estly used by health care authorities to assess health
care performance.
The Spanish National Health Service (NHS) experi-
ence is built on the insight from the Healthcare Cost
and Utilization Project by the US Agency for Healthcare
Research and Quality [10] and the requirements by the
OECD [11]. In spite of the efforts made in building a
valid tool concerns remain about whether PSI are
appropriate to inform hospital performance. Beyond the
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have pointed out to flaws in their capacity to attribute
excess-cases to hospitals by detecting true incident
adverse events [14-23]. Less has been written on their
empirical properties, mainly because of their local nat-
ure; in particular, to what extent PSI show systematic
variation on adjusted-incidence (as opposed to random)
and, their ability to provide precise estimates and there-
fore, being sensitive to detect providers over the
expected. In this sense, several works on similar topics,
have partially addressed some of these issues [24-26].
This paper aims at testing the empirical properties of
five PSI as well as their ability to respond relevant ques-
tions for concerned users; thus: a) Are differences in PSI
rates across hospitals systematic?; b) Do PSI measure
differences among hospital-providers as opposed to dif-
ferences among patients?; and, c) Are measurements
precise enough and able to detect providers with a
higher (lower) than expected number of cases?
Methods
Study design, population and setting
An empirical validation study, based on administrative
data, was carried out. All 2005 and 2006 publicly-funded
hospital discharges were used to retrieve eligible
patients. In order to reduce random noise on estimates,
hospitals with less than 30 eligible cases were excluded.
Five PSI were analyzed for the purposes of this study:
Death in low-mortality DRGs (MLM); decubitus ulcer
(DU); postoperative pulmonary embolism or deep vein
thrombosis (PE-DVT); infections due to medical care,
including catheter-related infections (CRI) and post-
operative sepsis (PS). The number of cases (numerators)
and eligible admissions (denominators) are shown in
Table 1. The election of these five indicators was based
on a previous report on the validity of ARQH PSI indi-
cators for the Spanish case [23].
For the purpose of this study a Spanish version from
the AHRQ PSI algorithms was used. PSI definitions by
AHRQ -4.1 version- were subject to a local validation
process, accounting for differences with respect to the
US healthcare system (i.e., ICD 9
th version and DRG
version in use, as well as some coding characteristics)
with a view of improving face validity for the Spanish
context. Although it has been described elsewhere
[23,27], it might be useful to highlight that a dedicated
consultation group involving clinicians and coders set
about to examine and adapt as needed, both numerators
and denominators for each indicator. In the particular
case of MLM -an empirically built indicator- the list of
low mortality DRGs was re-defined for the Spanish case.
The overall correlation between original AHRQ and
Spanish PSI definitions as to flag events in the hospitals
under study was high across the five indicators, ranging
from 0.75 in PE-DVT to 0.95 in PS.
Main endpoints
Three main endpoints were studied: a) Systematic varia-
tion defined as an Empirical Bayes value different to
zero; b) Cluster effect defined as a rho statistic value dif-
ferent to zero; c) Sensitivity as the statistically significant
difference between the observed and the expected, as
provided by the residual analyses in a multilevel
approach.
Analyses
Adjusted-incidence (I) for each PSI -except MLM- and
hospital were calculated. Crude incidence was used in
t h ec a s eo fM L Md u et oi t sq u a s i - s e n t i n e le v e n tn a t -
ure. Variation in incidence was calculated using the
ratio of variation between hospitals in percentile 95
and percentile 5 (RV95-5), and the ratio of variation
between hospitals in percentile 75 and percentile 25
(RV75-25).
Table 1 PSI adjusted-incidence and variation across hospitals
Mortality in Low-
mortality DRGs
Decubitus ulcer Catheter-related
infection
Postoperative
sepsis
Cases 683 18,738 5,375 9,727 10,602
Patients at risk 1,255,647 2,190,633 2,954,018 1,949,434 612,590
Adjusted-incidence
* (range
P5P95)
0.54 0 to 1.41 7.69 6.00 to
12.63
1.82 1.59 to
2.20
4.99 4.20 to
6.10
17.3 15.30 to
20.26
Statistics of variation
RV95-5(CI95%) 12.88 9.36-
14.98
2.03 1.79-2.32 1.37 1.31-1.44 1.39 1.33-1.58 1.31 1.24-1.35
RV75-25(CI95%) 7.06 4.77-7.88 1.40 1.33-1.44 1.15 1.11-1.17 1.15 1.13-1.18 1.12 1.10-1.14
EB (CI95%) 0.32 0.19-0.51 0.34 0.25-0.45 1.14. 0.85-1.51 0.19 0.12-0.28 0.30 0.19-0.45
* Adjusted by: age, gender and Elixhauser’s comorbidities except in PSI#2 where crude incidence is shown. Empirical Bayes statistic is a measure of systematic
variation -variation beyond chance. A value different to 0 would represent systematic variation; as for its magnitude, the higher the value the more the
systematic variation
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questions on PSI empirical properties were carried out,
once variation in the incidence of adverse events was
calculated. Hereinafter, we describe these methods.
Are differences across hospitals systematic rather than
random?
We used an observed to expected approach, being the
observed the counts of adverse events in each hospital
under study, and the expected the predicted cases from
a logistic regression considering as covariates the
recorded age, sex and comorbidities for each patient.
(An adaptation from the ARQH version [28] was used
to retrieve comorbidities)
Given both observed and expected counts, the Empiri-
cal Bayes statistic (EB) was estimated following a two-
step hierarchical model. The first step assumes that,
conditional on the risk ri, the number of counts yi fol-
lows a Poisson distribution, yi|ri ~ Poisson (eiri), whereas
in the second one, heterogeneity in rates is modelled
adopting a common distribution π for the risk ri (or for
its logarithm), ri ~ π (r|θ), with θ the vector of para-
meters of the density function. EB statistic is based on
the assumption that the log-relative risks are normally
and identically distributed, log (ri)~N ( μ, s2).
In order to assess the alternative hypothesis, confidence
intervals for the observed statistics were derived. In order
to avoid parametric assumptions on the distribution of
observed cases, we used a non-parametric methodology
-a sampling with 2,000-time re-sampling method for each
one of the simulated samples. Credibility intervals from
percentiles 2.5 and 97.5 were obtained [29].
Do PSI measure differences among hospital-providers as
opposed to differences among patients?
Classically, risk adjustment has been used to compare
providers, assuming that all patients have a homoge-
nous propensity to have the outcome of interest, wher-
ever the place they are treated. We could otherwise
hypothesize that this propensity is more similar among
patients within a hospital than among patients from
different hospitals -this would be the so called cluster
effect. If true, classical methods ignore this effect and
mislead the true estimates of variation. Alternatively,
the multilevel approach considers the cluster effect
(heterogeneity across hospitals) in the variance estima-
tion, producing sounder estimates and a better under-
standing on how context (i.e., hospital of treatment)
affects event rates [26].
In our study, to answer the above mentioned question,
the existence of cluster effect (hospital effect) was tested
by using a 2-level logistic modelling, where patients
were nested into hospitals. The outcome variable was
the PSI of interest, and the covariate variables were age,
sex and the Elixhauser’s comorbidities (EC) [28]. A
model was tailored for each PSI (except MLM, which is
considered a quasi-sentinel event), testing EC as covari-
ates, taking into consideration the clinical reasoning -i.
e., not all EC were used in all PSI-, and the magnitude
of the association (OR ≥ 2) to avoid spurious findings
due to the massive samples used in the study. The mul-
tilevel model was an extension of the previously esti-
mated individual logistic models (c statistic was used to
assess their goodness of fit) [30].
The degree of similarity of PSI events among provi-
ders was tested by using the rho statistic and its confi-
dence intervals (type 1 error of 5%). The unobserved
individual error followed a logistic distribution with
individual variance equal to π
2/3 [26].
Finally, the Median Odds Ratio (MOR) statistic (and
its confidence intervals), a measure of the variation
among clusters (hospitals in our study) was estimated by
comparing pairs of patients with the same covariates
from two, randomly chosen, different clusters [31].
MOR provides information on how heterogeneity across
hospitals increases the individual odds of experiencing
the outcome of interest.
Are measurements able to detect hospitals with a higher
than expected number of cases?
This is a key question in the study as PSI are infrequent
events, and imprecise measures and poor sensitivity are
expected.
Given the existence of cluster effect, the natural way
to assess the statistically significant difference between
each hospital PSI rate and the expected rate, is to
compute (and plot) shrunken residuals derived from
the multilevel method. Shrunken residuals would dis-
entangle the true hospital variation from that due to
random [32].
.
For the purposes of this study, the residual in each
hospital and its standard error were estimated. The resi-
dual (μj) would represent the difference between the
observed and the expected rate (μoj), being the expected
the estimated average PSI rate for all the hospitals
under study. Residual graphs exhibiting each hospital
effect (and its confidence interval) around the average
value (constant value for all hospitals as the expected
one) were plotted. Residuals were assumed to follow a
Gaussian distribution, N ~ (0, 1).
Data sources
The 2005 and 2006 hospital discharges dataset (CMBD)
was used to obtain numerators and denominators for
each indicator -i.e. PSI inclusion and exclusion criteria.
CMBD records the activity performed by all publicly
funded hospitals across the country, enforced to provide
this information in a yearly-basis. The register records,
in a systematic and homogenous way, information from
each patient discharge; specifically: age, sex, diagnosis of
admission, secondary diagnoses (up to 30), length of
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nostic and therapeutic procedures performed. The regis-
ter started off its activity in the mid 90s.
Results
A total of 6.2 million discharges (between 171 and 175
hospitals depending on the indicator) were retrieved,
once the new Spanish definitions were implemented.
Admissions at risk ranged from 612,590 in post-opera-
tive sepsis to 2,954,018 in catheter-related infection.
Adjusted-incidence ranged from 0.54 deaths per 1,000
patients admitted in low-mortality DRGs to 17.3 in
postoperative sepsis per 1,000 eligible patients. (Table 1)
Are differences among hospitals systematic?
The highest variation in the rate of adverse events
among hospitals was observed in MLM [RV5-95 = 12.88
(CI95%: 9.36 to 14.98); RV25-75 = 7.06 (CI95%: 4.77 to
7.88)] being the smallest variation that in PS [RV5-95 =
1.31 (CI95%: 1.24 to 1.35); RV25-75 = 1.12 (CI95%:1.10
to 1.14)]. Figure 1 allows a visual comparison of the var-
iation across the five PSI.
In accordance to the Empirical Bayes statistic, varia-
tion was observed to be systematic in all indicators, ran-
ging from 0.19 (CI95%: 0.12 to 0.28) in the case of PE-
DVT to 0.34 (CI95%: 0.25 to 0.45) in DU (Table 1).
Do they measure differences among hospital-providers?
Multilevel logistic regressions were modelled to deter-
mine the effect of the hospital, once patient case-mix
was adjusted. Although most of the variance was
explained by patient-related factors ranging from 64%
in PS to 79% in DU in accordance to the area under
the curve, still a significant proportion of the variance
was explained by the hospital: from a small rho value
o f6 %i nt h ec a s eo fM L M( C I 9 5 % :3 %t o1 1 % )t oa
high rho value of 24% (CI95%: 20% to 30%) in CRI.
(Table 2)
In the median case, as expressed by MOR, the var-
iance among hospitals increased the individual risk
expressed by ORs: by a 53% (MOR = 1.53 (CI95%:1.35
to 1.81) in the case of MLM, by a 79% in the risk of
having DU attributable to the care received, by more
than 2.6 times in the risk of experiencing a CRI, a 53%
of suffering a PE-DVT afters u r g e r ya n da6 9 %o fh a v -
ing a PS.
Are measurements precise enough and able to detect
hospitals with a higher than expected number of cases?
As observed in Figure 2, after the risk adjustment, a
remarkable amount of hospitals were found to be statis-
tically positioned above the expected -average rate of
adverse events predicted for the hospitals under study.
So, 19 hospitals (11% of the sample) in the case of
MLM, 46 hospitals (26%) in DU, 114 hospitals (35%) in
CRI, 39 hospitals (22%) in PE-DVT, and 53 hospitals
(31%) in PS were flagged as “underperformers”.
Discussion
Five PSI have been considered for empirical validation
in public acute-care hospitals across Spain. All of them
showed systematic variability (variation beyond chance),
were proven to have cluster effect, and were able to
detect hospitals above the expected. Nevertheless, sev-
eral questions should be drawn out to provide a
nuanced statement on their usefulness.
Is the estimated variation systematic or due to chance?
Except in the case of MLM, since it is considered a
quasi-sentinel event, we should know more about the
basal distribution of adverse events to properly answer
this question; however, we might assume, given the nat-
ure and rationale behind the safety indicators, that this
distribution is expected to be close to zero.
Our approach was precisely based on testing the
alternative hypothesis throughout the estimation of
robust Empirical Bayes confidence intervals against
zero as the null value. The precision of the estimated
intervals together with the distance between the lower
limit and the zero value (the closest figure corre-
sponded to 0.12, in PE_DVT) support the hypothesis
that the variation observed is systematic, rather than
random.
Figure 1 Variation in adjusted-incidence by PSI.E a c hd o t
represents the adjusted-incidence of adverse events in a specific
hospital. Incidence is computed as a mean-centred log-incidence to
allow the comparison among events with different basal incidence.
Legend: y axis: log-adjusted-incidence. x axis: (left to right) Mortality
in Low-Mortality DRGs, Decubitus Ulcer, Catheter-related Infection,
Post-operative Pulmonary Embolism or Deep-vein Thrombosis and
Post-operative Sepsis
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Mortality in Low-mortality DRGs Model 1
Hospital random effect
Model 2
adds age-sex fixed-effect
Model 3
adds comorbidity fixed-effect
Patient variables (OR 95% CI)
Constant 0.001 (0.0005 to 0.007)
Measures of clustering
Hospital level variance (SE) 0.20 (0.07)
Rho (95% CI) 0.06 (0.03 to 0.11)
MOR (95% CI) 1.53 (1.35 to 1.81)
Decubitus Ulcer Model 1
Hospital random effect
Model 2
adds age-sex fixed-effect
Model 3
adds comorbidity fixed-effect
Patient variables (OR 95% CI)
Constant 0.008 (0.007 to 0.009) 0.00015 (0.00013 to 0.0002) 0.00018 (0.00015 to 0.0002)
Age 1.053 (1.052 to 1.055) 1.046 (1.045 to 1.047)
Sex 1.11 (1.08 to 1.14) 1.14 (1.09 to 1.17)
Paralysis 5.05 (4.81 to 5.31)
Other neurological disorders 3.74 (3.59 to 3.89)
Diabetes w chr. complications 1.87 (1.79 to 1.99)
Weight loss 5.16 (4.85 to 5.47)
Fluid And electrolyte disorders 2.97 (2.83 to 3.13
Measures of clustering
Hospital level variance (SE) 0.54 (0.43 to 0.68) 0.46 (0.37 to 0.58) 0.38 (0.29 to 0.47)
Rho (95% CI) 0.14 (0.12 to 0.17) 0.12 (0.10 to 0.15) 0.10 (0.08 to 0.13)
MOR (95% CI) 2.01 (1.86 to 2.18) 1.91 (1.78 to 2.06) 1.79 (1.68 to 1.92)
Catheter-related infection Model 1
Hospital random effect
Model 2
adds age-sex fixed-effect
Model 3
adds comorbidity fixed-effect
Patient variables (OR 95% CI)
Constant 0.001 (0.0009 to 0.0012) 0.0012 (0.001 to 0.0014) 0.0012 (0.001 to 0.0015)
Age 1.017 (1.016 to 1.018) 1.014 (1.013 to 1.015)
Sex 0.47 (0.44 to 0.49) 0.49 (0.46 to 0.51)
Peripheral vascular disease 2.05 (1.84 to 2.29)
Paralysis 2.20 (1.93 to 2.56)
Weight loss 3.63 (3.03 to 4.35)
Fluid And electrolyte disorders 2.36 (2.09 to 2.66)
Measures of clustering
Hospital level variance (SE) 1.10 (0.84 to 1.44) 1.11 (0.85 to 1.45) 1.05 (0.80 to 1.38)
Rho (95% CI) 0.25 (0.20 to 0.31) 0.25 (0.20 to 0.31) 0.24 (0.20 to 0.30)
MOR (95% CI) 2.71 (2.39 to 3.13) 2.72 (2.39 to 3.14) 2.65 (2.38 to 3.06)
Postoperative PE or DVT Model 1
Hospital random effect
Model 2
adds age-sex fixed-effect
Model 3
adds comorbidity fixed-effect
Patient variables (OR 95% CI)
Constant 0.0046 (0.0043 to 0.005) 0.00065 (0.00055 to 0.0007) 0.00059 (0.00052 to 0.0007)
Age 1.031 (1.029 to 1.032) 1.029 (1.028 to 1.03)
Sex 0.96 (0.92 to 1.002) 1.02 (0.82 to 1.06)
Pulmonary circulation disease 2.39 (2.16 to 2.66)
Paralysis 2.32 (2.07 to 2.58)
Lymphoma 2.14 (1.69 to 2.69)
Metastatic cancer 2.80 (2.56 to 3.03)
Solid tumor w/o metastasis 1.84 (1.65 to 2.03)
Coagulopthy 2.89 (2.56 to 3.25)
Weight loss 2.58 (2.25 to 2.94)
Measures of clustering
Hospital level variance (SE) 0.26 (0.19 to 0.33) 0.24 (0.19 to 0.31) 0.20 (0.15 to 0.26)
Rho (95% CI) 0.07 (0.06 to 0.09) 0.07 (0.05 to 0.09) 0.06 (0.04 to 0.07)
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than to patients?
If this was not the case, PSI would not be useful in
describing what they are aimed to, which is to elicit dif-
ferences attributable to health care.
Our approach sought to elicit the hospital effect by
estimating the existence of variation beyond the case-
mix of patients treated -throughout the namely cluster
effect. As mentioned in the results, in the studied PSI a
noticeable part of variation was attributed to the hospi-
tal where the patients were treated. However, it might
be argued that in a multilevel approach, this finding is
quite dependant on the goodness of the risk adjustment
-the worse the adjustment at patient level, the higher
the proportion of variance that could be eventually
explained by the hospital-level. This is particularly true
in the case of studies using administrative data, where
the limited information available on specific patient
characteristics might reduce the goodness of risk-adjust-
ment methods.
A way to mitigate this limitation is to reduce the
extra-variance due to differences in case-mix that the
model is unable to capture, by modelling the largest
hospitals. These are teaching hospitals with more than
450 beds, able to provide high-tech services, and ulti-
mately, homogeneous with regard to the patient case-
mix, particularly in studies where sample size is as huge
as ours.
The results of this exercise showed a significant reduc-
tion on rho-statistic values, backing the hypothesis that
the strategy of risk-adjustment was missing some rele-
vant patient characteristics. Even though this finding,
cluster effect remained: rho-statistic equals 0.06 (CI95%:
0.03 to 0.11) in MLM; 0.05 (CI95%: 0.03 to 0.07) in DU;
0.10 (CI95%: 0.07 to 0.14) in CRI; 0.02 (CI95%: 0.01 to
0.03) in PE-DVT; and, 0.03 (CI95%: 0.03 to 0.05) in PS.
Are results dependant on the coding practices affecting
Elixhauser comorbidities?
A particular phenomenon that could also affect the clus-
ter estimates, and ultimately the reliance on PSI, is the
differential coding intensity across hospitals. In fact, the
number of secondary diagnoses has been already proven
to influence the international comparisons [21]. In the-
ory, if this variation was closely related to coding inten-
sity in hospitals, the cluster effect would suffer an
important reduction when the number of secondary
diagnoses was considered as a factor in the multilevel
models; otherwise, it would be very much related to the
patients, thus affecting the risk adjustment estimates.
For the purpose of this exploration the number of sec-
ondary diagnoses was categorized using the median
value (4 secondary diagnoses) as a threshold. In general
terms, when both models were compared, a clear reduc-
tion in the Elixhauser comorbidity b coefficients,
together with stable rho-value estimates, were observed.
(Additional file 1) Given that the number of secondary
diagnoses absorbed part of the variance in the new
model and beta coefficients changed, variation is also
expected in the random effects estimation for each hos-
pital. However, an excellent correlation (Pearson coeffi-
cient values) between the original random effects and
the new ones was found: 0.83 in post-operative sepsis,
0.86 in post-operative PE-DVT, 0.94 in decubitus ulcer
and 0.96 in Catheter-related infection. On the other
hand, except in the case of decubitus ulcer the changes
in the statistical nature of the random effect (i.e. hospi-
tals found as statistically different that average turned
Table 2 Multivariate analyses. (Continued)
MOR (95% CI) 1.62 (1.53 to 1.73) 1.59 (1.51 to 1.70) 1.53 (1.45 to 1.63)
Postoperative sepsis Model 1
Hospital random effect
Model 2
adds age-sex fixed-effect
Model 3
adds comorbidity fixed effect
Patient variables (OR 95% CI)
Constant 0.014 (0.013 to 0.015) 0.006 (0.005 to 0.007) 0.0068 (0.0059 to 0.0077)
Age 1.022 (1.021 to 1.023) 1.019 (1.018 to 1.02)
Sex 0.63 (0.61 to 0.66) 0.64 (0.61 to 0.66)
Congestive heart failure 2.51 (2.36 to 2.69)
Paralysis 2.16 (1.95 to 2.39)
Weight loss 3.39 (2.91 to 3.89)
Measures of clustering
Hospital level variance (SE) 0.28 (0.21 to 0.37) 0.31 (0.24 to 0.41) 0.30 (0.23 to 0.39)
Rho (95% CI) 0.08 (0.06 to 0.10) 0.09 (0.07 to 0.11) 0.08 (0.07 to 0.11)
MOR (95% CI) 1.65 (1.55 to 1.78) 1.70 (1.59 to 1.84) 1.69 (1.58 to 1.82)
Estimates for hospital (clustering) and individual effects
A Rho statistic value different to 0 represents the existence of cluster effect -the propensity of having an outcome is more similar among the patients within a
hospital, that among patients from different hospitals; as for the magnitude of rho, the more the value, the greater the clustering
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Figure 2 Shrunken residuals (and standard errors) by PSI. y axis: random effect (standard error). x axis: hospitals sorted by random effect a.
Mortality in Low-Mortality DRGs. Note: Random effect (and standard error) after modelling the cluster effect. No patient variables were
adjusted as Mortality in Low-Mortality DRGs is considered a sentinel-like event. b. Decubitus ulcer. Note: Random effect (and standard error)
after modelling the cluster effect. Patient variables adjusted in the model were: age, sex, paralysis, other neurological disorders, diabetes with
chronic complications, weight loss and fluid and electrolytic disorders. c. Catheter-related infections. Note: Random effect (and standard error)
after modelling the cluster effect. Patient variables adjusted in the model were: age, sex, peripheral vascular disease, paralysis, weight loss, fluid
and electrolytic disorders. d. Postoperative PE or DVT. Note: Random effect (and standard error) after modelling the cluster effect. Patient
variables adjusted in the model were: age, sex, pulmonary circulation disease, paralysis, lymphoma, metastatic cancer, solid tumor w/o metastasis,
coagulopathy and weight loss. e. Postoperative sepsis. Note: Random effect (and standard error) after modelling the cluster effect. Patient
variables adjusted in the model were: age, sex, congestive heart failure, paralysis, and weight loss
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null or negligible.
Are PSI precise enough to detect hospitals with rates
above the expected?
Although PSI are quite infrequent events, shrunken resi-
duals from the multilevel analysis have been proven pre-
cise enough to detect hospitals above the expected.
Figure 2 showed some quite straightforward images on
this capacity. Nevertheless, determining in what manner
cluster effect might be influenced by either outlier hos-
pitals or the extra-variance attributable to the mix of
hospitals within the sample is also needed.
With regard to the former, the estimation barely chan-
ged once those outlier values -easily identifiable at the
two ends of the distribution in Figure 2- were excluded
(data not shown). Most important is the latter one. To
understand this effect, new residuals were estimated and
plotted in those most a priori homogeneous centres, the
largest ones as described in previous paragraphs. As
observed, except in the case of MLM where heterogene-
ity across hospitals was the underlying reason for results
(just 4 out of 47 hospitals were statistically above the
expected in this second analysis), in the remaining PSI,
this capacity held noticeably high: 23% of the hospitals
were flagged above the expected in decubitus ulcer, up
to 36% in catheter-related infection, 25% in the case of
postoperative pulmonary embolism or deep vein throm-
bosis, and up to 28% in the case of postoperative sepsis.
(Additional file 2)
Should policy-makers and managers trust PSI?
Our work aimed at shedding light on some empirical
properties that PSI are supposed to accomplish, in
order to be useful for safety measurement and, ulti-
mately, allow concerned users an informed quality
management. Thus, representing systematic variation
across providers -ruling out randomness as an alterna-
tive explanation of the differences-, and flagging hospi-
tals as potential underperformers regardless the mix of
patients they treat. However, a proper use requires
debating upon two lessons learnt in this study, and
reflecting upon other aspects that were not part of our
work.
As for the lessons learnt with the studied PSI, due to
the aforementioned flaws in adjusting patient-risks, we
need to be aware that hospitals with more complexity
might be signalled as false bad performers, particularly if
they do not properly report secondary diagnoses. Sec-
ondly, the hospital effect (cluster effect) does exist, quite
consistently throughout different statistic models; how-
ever, its magnitude clearly decreases when studying
homogeneous hospital-providers. Although obvious, this
message directly points towards comparing comparables,
particularly, when risk adjustment is expected to be sub-
optimal.
As for the reflection on other issues not addressed in
this exercise, it is worth pointing out that the study of
the empirical properties is just a partial view on PSI’s
validity. Further debate upon other validity issues ought
to be pursued in order to fully trust on PSI usage. As
for this purpose we have to be able to answer whether
PSI measure what are supposed to measure. In this
work, we have assumed construct validity since PSI
were carefully developed for safety measurement pur-
poses, [10,11] and face validity has been granted in
advance for the Spanish case, by carrying out an ad hoc
face-validity project [23]. However, criterion validity -the
ability for an indicator to flag true positive cases and
true negative cases by comparison with a gold standard-
has to be specifically addressed, in context. Fortunately,
for the Spanish NHS, a recent piece of research on sur-
gical discharges shed some light on criterion validity
[33]. In general terms, the five PSI were proven to have
a quite good performance in terms of positive likelihood
ratio (+LR). The most conservative estimation yielded a
+ LR of 26.8 in decubitus ulcer, a + LR of 406.3 in
catheter-related infection, a + LR of 149.3 in PE-DVT
and a + LR of 25.32 in postoperative sepsis. These fig-
ures seemed high enough to adopt the use of these PSI
as a screening tool; except in the case of decubitus
ulcer, clearly affected by underreporting (false negative
cases) and the existence of present-on-admission ulcers
(false positive cases).
Some additional effort should be made on evaluating
the PSI stability over time (out of the scope of this
work), but in the meantime, taking the studied PSI as
screening tools, assessing wisely the limits pointed out
along this work in specific contexts, might help to iden-
tify those centres from which best practice lessons can
be drawn out and those where intervention is clearly
needed.
Conclusion
Five PSI showed reasonable empirical properties to
screen healthcare performance in Spanish hospitals, par-
ticularly in the largest ones. However, ability to flag hos-
pitals beyond the expected was limited in Mortality in
Low-Mortality DRGs due to its larger standard errors,
and risk for hospitals misclassification in decubitus ulcer
remained.
Additional material
Additional file 1: The effect of the number of secondary diagnoses.
It shows the recalibration of each model using as a factor the number of
secondary diagnoses. Tables show both the estimates before and after
the adjustment.
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Page 8 of 10Additional file 2: Shrunken residuals (and standard errors) by PSI.I t
shows the residuals and standard errors for the largest hospitals in the
sample (n = 47).
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